Pruritus Therapeutic Market Growth Accelerates: Strategic Forecast Predicts $22.02 Billion by 2029

Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.

What Will the Pruritus Therapeutic Industry Market Size Be by 2025?
In recent years, there has been robust growth in the pruritus therapeutic market size. It is expected to increase from $14.29 billion in 2024 and reaching $15.43 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 8.0%. The notable growth during the past period can be credited to factors like an escalating prevalence of pruritus, breakthroughs in research and development initiatives, an expanding elderly population, growth in the healthcare infrastructure, rising patient awareness, and strategic collaborations and partnerships.

What's the Long-Term Growth Forecast for the Pruritus Therapeutic Market Size Through 2029?
The market size for pruritus therapeutics is projected to experience robust growth in the upcoming years, expanding to $22.02 billion by 2029 with a compound annual growth rate of 9.3%. Factors promoting this growth during the forecast period include progressive research, growth in emerging markets, increased healthcare spending, customised medicine trends, and regulatory backing for innovation. Key market trends forecasted include the integration of telemedicine and digital health, technological progress, solutions in telehealth and digital health, evolution in the global regulatory environment, biologics and immunomodulators, and focus on patient-centric methods.

View the full report here:
https://www.thebusinessresearchcompany.com/report/pruritus-therapeutic-global-market-report

What Are the Key Growth Drivers Fueling the Pruritus Therapeutic Market Expansion?
The rising number of skin disorder cases have notably fuelled the expansion of pruritus therapeutics. References to skin conditions pertain to dermatologic issues or skin disorders like acne, eczema, skin cancer, psoriasis, and vitiligo which impact the skin's health. Pruritus therapeutics prove helpful in the treatment of a range of skin diseases, mainly because most skin disorders exhibit pruritus as a main symptom. For example, in April 2022, as reported by the American Academy of Dermatology Association, a U.S. dermatology association, it is anticipated that melanoma will cause 7,650 deaths in 2022; this includes 5,080 men and 2,570 women. Moreover, in January 2023, as per the American Cancer Society, a U.S. voluntary agency, an estimated 97,610 new cases of melanoma are predicted to be diagnosed in the U.S. in 2023, comprising around 58,120 men and 39,490 women. Consequently, the increased instances of skin disorders are set to propel the pruritus therapeutic market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9925&type=smp

What Are the Key Trends Driving Pruritus Therapeutic Market Growth?
A prominent trend that is gaining traction in the pruritus therapeutic market is product innovation. Key players in the market are concentrating their efforts on manufacturing innovative drugs and treatments for pruritus and its related disorders. A case in point is Maruho Co., Ltd., a pharmaceutical firm based in Japan, introduced the anti-IL-31 receptor, categorized as a humanized monoclonal antibody labeled as Mitchga Subcutaneous Injection 60 mg Syringes in August 2022. This is used to treat itching that comes with atopic dermatitis. It stands as the premier antibody drug that blocks IL-31 signaling. IL-31 is a neuroimmune cytokine2 that is associated with pruritus and skin inflammation which contributes to the progression of atopic dermatitis3,4. It works by halting IL-31 from binding to its receptor, thus preventing itchiness and skin inflammation linked to atopic dermatitis.

How Is the Pruritus Therapeutic Market Segmented?
The pruritus therapeutic market covered in this report is segmented -

1) By Type: Corticosteroids, Antihistamines, Local Anesthetics, Counterirritants, Immunosuppressant, Calcineurin Inhibitors, Others Types
2) By Disease Type: Atopic Dermatitis Or Eczema, Allergic Contact Dermatitis, Urticaria, Cutaneous T-Cell, Other Disease Types
3) By Application: External Use, Oral, Injection
4) By End Use: Hospitals, Clinics, Other Uses

Subsegments:
1) By Corticosteroids: Topical Corticosteroids, Systemic Corticosteroids
2) By Antihistamines: First-Generation Antihistamines, Second-Generation Antihistamines
3) By Local Anesthetics: Topical Local Anesthetics, Injectable Local Anesthetics
4) By Counterirritants: Menthol-Based Products, Camphor-Based Products
5) By Immunosuppressants: Systemic Immunosuppressants, Topical Immunosuppressants
6) By Calcineurin Inhibitors: Tacrolimus, Pimecrolimus
7) By Other Types: Antidepressants, Phototherapy Treatments, Herbal Remedies

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=9925&type=smp

Which Companies Are Leading the Charge in Pruritus Therapeutic Market Innovation?
Major companies operating in the pruritus therapeutic market include Astellas Pharma Inc., Bristol-Myers Squibb Company, Cipla Inc., Eli Lilly and Company, Galderma Laboratories LP, GlaxoSmithKline plc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, Abbott Laboratories, Almirall SA, Eisai Co. Ltd., Glenmark Pharmaceuticals Ltd., Ipca Laboratories Ltd., Lupin Chemicals Ltd., Cara Therapeutics Inc., EPI Health LLC, AbbVie Inc., Albireo Pharma Inc., Bayer AG, Bausch Health Companies Inc., Regeneron Pharmaceuticals Inc., Huapont Life Sciences Co. Ltd., LEO Pharma AS, MC2 Therapeutics Ltd., Novan Inc., Trevi Therapeutics Inc., UCB SA, Viatris Inc., Teva Pharmaceutical Industries Ltd.

Which Regions Are Leading the Global Pruritus Therapeutic Market in Revenue?
North America was the largest region in the pruritus therapeutic market in 2024. The regions covered in the pruritus therapeutic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9925

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe - +44 7882 955267,
Asia: +91 88972 63534,
Americas - +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.